These workshops are interactive small-group sessions moderated by subject experts.
They tackle hot topics better suited to longer discussion, providing attendees and speakers with the opportunity to collaborate and brainstorm practical solutions to two key challenges facing the field in 2025.
8:00 am Coffee & Registration
9:00 am Workshop A – Assessing the Impacts of and Planning for the New Administration
Synopsis
- Monitoring the impact of new HHS leaders for cell and gene therapy approvals
- What can you expect for IRA drug pricing provisions?
- How have pricing and reimbursement policies evolved thus far, and how are they likely to evolve in the coming years?
- What have been the immediate impacts on CGT pricing and reimbursement?
- Based on early learnings, how should drug manufacturers adapt to changes to ensure coverage and access to their therapies?
12:00 pm Lunch & Networking
1:00 pm Workshop B – Putting Innovative Payment Models into Practice
Synopsis
- An overview of innovative payment models (IPMs) being used to mitigate risk, reinforce value, and ensure access to CGTs
- Exploring recent trends in IPMs being favoured by payers, providers, and third-party companies, and the reasons why
- How do these differ between large payers, small payers, and employers?
- Practical advice for selecting an outcome to form a value-based agreement
- For how long will value-based outcomes still be needed?
- How can value-based contracts be adapted to suit heterogenous conditions?
- Ensuring innovative payment models will work in practice in the context of the US rebate model